For example: Apple Inc, UTIL, Aluminum
Charles River Laboratories International Inc
NYSE:CRL
Market Close 11/27
230.16 USD +3.81 (+1.68%)
OPEN:
226.35
DAY RANGE:
226.07 - 230.16
PE:
31.26
PB:
4.08
PS:
2.83
WTD % -1.02
MTD % 1.08
QTD % 1.64
YTD % 50.67
* Updated at market close
Charles River Laboratories International Inc (NYSE:CRL) opened on Nov 27, 2020 at 226.35 USD and increased by 1.68%. The intraday price range was 226.07 - 230.16 USD and eventually ended the session at 230.16 USD. The stock trade volume was 73,000.00 shares. The company's 52-week range is 95.58 - 257.88 USD.
Trading Statistics (Market Close Nov 27, 2020)
Market Cap 11.43 B
Outstanding Stock 48.10 M
Dividend 0.00
Dividend Yield 0.00
EPS 4.54
YTD Change 50.67%
52 Week's Range 95.58 - 257.88
Key Ratio & Margins (Market Close Nov 27, 2020)
Price/Earning 31.26
Price/Book Value 4.08
Price/Sales 2.83
ROA -
ROE -
Debt/Equity 2.16
Company Self Description
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services worldwide. The company operates through three segments: Research Models and Services, Discovery and Safety Assessment, and Manufacturing Support. It was founded in 1947 and is headquartered in Wilmington, Massachusetts, United States.
Business Information
Charles River Laboratories International Inc
Sector Health Care
Industry Life Sciences Tools & Services
Exchange NYSE
Top Competitors (Market Close Nov 27, 2020)
  CRL ICLR TECH QGEN
Daily Change (%) 1.68 1.54 -1.36 2.62
WTD (%) -1.02 0.77 -2.38 2.71
MTD (%) 1.08 6.01 17.92 2.21
QTD (%) 1.64 0.03 20.15 -7.21
YTD (%) 50.67 10.98 35.60 43.46
52-Week Change (%) 56.70 16.87 34.08 13.61
Stock Performance (Market Close Nov 27, 2020)
  CRL ICLR TECH QGEN
Daily Change (%) 1.68 1.54 -1.36 2.62
WTD (%) -1.02 0.77 -2.38 2.71
MTD (%) 1.08 6.01 17.92 2.21
QTD (%) 1.64 0.03 20.15 -7.21
YTD (%) 50.67 10.98 35.60 43.46
52-Week Change (%) 56.70 16.87 34.08 13.61
Key Fundamentals (Market Close Nov 27, 2020)
  CRL ICLR TECH QGEN
Market Cap 11.43 B 10.34 B 11.47 B 10.93 B
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin 8.90% 0.00 17.30% 12.70%
P/E Ratio 31.26 21.68 61.85 41.01
Price to Sales Ratio 2.83 0 10.67 5.20
Price to Book Ratio 4.08 5.16 5.15 2.96
Enterprise Value to EBITDA 13.66 15.89 29.24 17.83
ROA - 14.30% 6.80% 3.50%
ROE - 25.40% 11.00% 7.40%
Debt/Equity 2.16 0.74 0.48 1.18
Asset Turnover Ratio 0.61 0 0.39 0.28
Current Ratio 1.61 2.18 5.01 2.22
Dividend Yield 0.00 - 0.60% 0.60%
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 2.27 B 1.86 B 1.68 B 1.36 B
Cost Of Revenue 1.43 B 1.16 B 1.04 B 832.21 M
Gross Profit 840.07 M 700.92 M 643.96 M 531.09 M
Selling General & Administrative Expenses 443.85 M 371.27 M 364.71 M 300.41 M
Research & Development 0.00 0.00 0.00 0.00
Operating Income 331.38 M 288.28 M 237.55 M 206.45 M
Net Income 226.37 M 123.36 M 154.77 M 149.31 M
EPS 4.72 2.60 3.29 3.21
Diluted EPS 4.62 2.54 3.23 3.13
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 657.57 M 604.57 M 601.53 M 585.30 M
Cost Of Revenue 419.46 M 392.79 M 375.11 M 369.10 M
Gross Profit 238.10 M 211.78 M 226.42 M 216.20 M
Selling General & Administrative Expenses 135.94 M 122.57 M 106.92 M 113.03 M
Research & Development 0.00 0.00 0.00 0.00
Operating Income 79.77 M 69.79 M 102.48 M 84.36 M
Net Income 43.73 M 55.13 M 59.67 M 60.37 M
EPS 0.90 1.14 1.25 1.25
Diluted EPS 0.88 1.11 1.23 1.22
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 897.84 M 826.63 M 656.83 M 559.23 M
Cash & Cash Equivalents 195.44 M 163.79 M 117.63 M 117.95 M
Total Assets 3.86 B 2.93 B 2.71 B 2.07 B
Total Current Liabilities 558.22 M 463.50 M 429.59 M 311.76 M
Total Liabilities 2.52 B 1.87 B 1.86 B 1.30 B
Shareholder's Equity 1.32 B 1.05 B 836.77 M 733.07 M
Outstanding Stock 48.10 M 47.36 M 47.33 M 46.62 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 1.01 B 866.18 M 897.84 M 838.17 M
Cash & Cash Equivalents 200.59 M 126.32 M 195.44 M 138.87 M
Total Assets 4.63 B 3.93 B 3.86 B 3.80 B
Total Current Liabilities 635.60 M 529.76 M 558.22 M 539.60 M
Total Liabilities 3.15 B 2.51 B 2.52 B 2.52 B
Shareholder's Equity 1.46 B 1.40 B 1.32 B 1.25 B
Outstanding Stock 48.75 M 48.23 M 48.10 M 48.03 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations 441.14 M 318.07 M 316.90 M 306.83 M
Capital Expenditures -140.05 M -82.43 M -55.29 M -63.25 M
Net Cash Flow from Investing Activities -955.00 M -72.59 M -692.67 M -327.62 M
Net Cash Flow from Financial Activities 558.06 M -208.48 M 380.76 M -7.26 M
Free Cash Flow 301.09 M 235.64 M 261.61 M 243.58 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations 129.55 M 318.07 M 316.90 M 306.83 M
Capital Expenditures -24.78 M -16.73 M -68.68 M -22.44 M
Net Cash Flow from Investing Activities -528.43 M -20.81 M -70.96 M -33.01 M
Net Cash Flow from Financial Activities 473.51 M -69.08 M 563,000.00 -147.08 M
Free Cash Flow 104.77 M -1.87 M 71.30 M 94.81 M
Key Ratios (Market Close Nov 27, 2020)
Valuation Ratios 2020 2019 2018 2017
P/E Ratio 31.26 30.58 23.67 47.37
Price to Sales Ratio 2.83 2.96 2.36 3.02
Price to Book Ratio 4.08 4.96 4.31 5.09
Enterprise Value to EBIT 20.00 19.00 19.00 22.00
Enterprise Value to EBITDA 13.66 13.70 12.66 14.91
Profitability Ratios 2020 2019 2018 2017
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - 6.20% 4.40%
ROE - - 18.50% 12.60%
Liquidity Ratios 2020 2019 2018 2017
Working Capital 339.61 M 363.12 M 227.24 M 247.47 M
Current Ratio 1.61 1.78 1.53 1.79
Efficiency & Capital Structure Ratios 2020 2019 2018 2017
Debt Equity Ratio 2.16 1.79 2.22 1.78
Asset Turnover Ratio - - 0.62 0.66
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.